Unknown

Dataset Information

0

Exendin-4 protects against post-myocardial infarction remodelling via specific actions on inflammation and the extracellular matrix.


ABSTRACT: Glucagon-like peptide-1 (GLP-1) is an insulin-releasing hormone clinically exploited for glycaemic control in diabetes, which also confers acute cardioprotection and benefits in experimental/clinical heart failure. We specifically investigated the role of the GLP-1 mimetic, exendin-4, in post-myocardial infarction (MI) remodelling, which is a key contributor to heart failure. Adult female normoglycaemic mice underwent coronary artery ligation/sham surgery prior to infusion with exendin-4/vehicle for 4 weeks. Metabolic parameters and infarct sizes were comparable between groups. Exendin-4 protected against cardiac dysfunction and chamber dilatation post-MI and improved survival. Furthermore, exendin-4 modestly decreased cardiomyocyte hypertrophy/apoptosis but markedly attenuated interstitial fibrosis and myocardial inflammation post-MI. This was associated with altered extracellular matrix (procollagen IαI/IIIαI, connective tissue growth factor, fibronectin, TGF-β3) and inflammatory (IL-10, IL-1β, IL-6) gene expression in exendin-4-treated mice, together with modulation of both Akt/GSK-3β and Smad2/3 signalling. Exendin-4 also altered macrophage response gene expression in the absence of direct actions on cardiac fibroblast differentiation, suggesting cardioprotective effects occurring secondary to modulation of inflammation. Our findings indicate that exendin-4 protects against post-MI remodelling via preferential actions on inflammation and the extracellular matrix independently of its established actions on glycaemic control, thereby suggesting that selective targeting of GLP-1 signalling may be required to realise its clear therapeutic potential for post-MI heart failure.

SUBMITTER: Robinson E 

PROVIDER: S-EPMC4344953 | biostudies-literature | 2015 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Exendin-4 protects against post-myocardial infarction remodelling via specific actions on inflammation and the extracellular matrix.

Robinson Emma E   Cassidy Roslyn S RS   Tate Mitchel M   Zhao Youyou Y   Lockhart Samuel S   Calderwood Danielle D   Church Rachel R   McGahon Mary K MK   Brazil Derek P DP   McDermott Barbara J BJ   Green Brian D BD   Grieve David J DJ  

Basic research in cardiology 20150301 2


Glucagon-like peptide-1 (GLP-1) is an insulin-releasing hormone clinically exploited for glycaemic control in diabetes, which also confers acute cardioprotection and benefits in experimental/clinical heart failure. We specifically investigated the role of the GLP-1 mimetic, exendin-4, in post-myocardial infarction (MI) remodelling, which is a key contributor to heart failure. Adult female normoglycaemic mice underwent coronary artery ligation/sham surgery prior to infusion with exendin-4/vehicle  ...[more]

Similar Datasets

| S-EPMC9945840 | biostudies-literature
| S-EPMC6277008 | biostudies-literature
| S-EPMC8277802 | biostudies-literature
| S-EPMC10774582 | biostudies-literature
| S-EPMC7701508 | biostudies-literature
| S-EPMC10074251 | biostudies-literature
| S-EPMC9336586 | biostudies-literature
| S-EPMC5319826 | biostudies-literature
| S-EPMC7391987 | biostudies-literature
| S-EPMC6893492 | biostudies-literature